At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Press Releases

Press Releases

All Releases
View Summary Amicus Therapeutics Provides Positive Global Regulatory Updates From EMA and FDA Meetings for Fabry Monotherapy
Mar 19, 2015
PDF 32.0 KB
View Summary Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates
Mar 3, 2015
PDF 33.0 KB
View Summary Amicus Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
Feb 26, 2015
PDF 16.1 KB
View Summary Amicus Therapeutics to Announce Full-Year 2014 Financial Results on March 3, 2015
Feb 25, 2015
PDF 16.2 KB
View Summary Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015
Feb 10, 2015
PDF 28.4 KB
View Summary Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015
Feb 10, 2015
PDF 21.5 KB
View Summary Amicus Therapeutics to Present at Leerink Global Healthcare Conference
Feb 4, 2015
PDF 16.0 KB
View Summary Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium
Jan 26, 2015
PDF 18.8 KB
View Summary Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
Jan 12, 2015
PDF 23.8 KB
View Summary Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study
Jan 8, 2015
PDF 27.1 KB
View Summary Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference
Dec 22, 2014
PDF 17.6 KB
View Summary Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI)
Dec 22, 2014
PDF 17.4 KB
View Summary Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease
Dec 11, 2014
PDF 22.2 KB
View Summary Amicus Therapeutics to Present at Oppenheimer Healthcare Conference
Dec 4, 2014
PDF 16.0 KB
View Summary Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option
Nov 24, 2014
PDF 21.9 KB
View Summary Amicus Therapeutics Prices Underwritten Offering of Common Stock
Nov 18, 2014
PDF 11.9 KB
View Summary Amicus Therapeutics Announces Public Offering of Common Stock
Nov 17, 2014
PDF 11.8 KB
View Summary Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology
Nov 15, 2014
PDF 20.4 KB
View Summary Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates
Nov 6, 2014
PDF 29.6 KB
View Summary Amicus Therapeutics Announces Timing of Third Quarter 2014 Financial Results, Upcoming Scientific Conference and Other Corporate Updates
Nov 3, 2014
PDF 11.4 KB
Showing 1-20 of 240 Page: 1 2 3 4 5 ... 12  Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy